OMGA: Omega Therapeutics Net Sales Margin

Public company logo of Omega (OMGA)

Omega Therapeutics possesses exceptional pricing power due to inelastic demand and the ability to precisely silence oncogenes without DNA modification. Adjusted net profit margin illustrates the financial efficiency of this approach. The value of 0.00 reflects the metric's balance as the epigenomic engineering leader develops its mRNA drug pipeline and OTX-2002, introducing innovations in regenerative medicine and precision gene control.

OMGA: omegatherapeutics.com Net Sales Margin 07/04/2022 - 03/08/2025

Summary analytical data breakdowns for Omega (OMGA)

- market value and analyst target forecast:
Basic company analysis:Omega Therapeutics
Flagship merchandise of Omega Therapeutics Inc

Sales margins reflect the share of net profit in every dollar of revenue, demonstrating the efficiency of cost management. Investors use this ratio to assess a business's ability to generate real income after deducting all expenses. By analyzing net profit shipment margins, one can identify hidden profitability compression. For Omega Therapeutics (OMGA), this metric is critical, as capital-intensive developments in epigenetics require strict control of operating expenses. The trend of this metric confirms the financial stability of the scientific team while creating innovative treatment methods.

Competitors of Omega Therapeutics (OMGA)

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|RCKT: Return on Sales by Net Profit|FDMT - Net Sales Margin|LXEO: Net Sales Margin|Korro Bio Inc. - Net Profit Rate|EDIT (editasmedicine.com) - Net Sales Margin|Net Margin SLN|Net Margin ProQR Therapeutics NV (PRQR)|Codexis - Net Return on Sales|Net Margin Sangamo SGMO|NAUT: Net Return on Sales|MGX: Return on Sales by Net Profit|Net Margin Precision BioSciences|GBIO (generationbio.com) - Return on Sales by Net Profit|Net Margin boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Net Sales Margin|Net Return on Sales IMNN (Imunon, Inc.)|Net Sales Margin PHIO|MBIO - Net Margin|Net Sales Margin RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Net Margin|Applied DNA - Net Sales Margin|Net Margin Bluebird Bio|ImmunoPrecise (IPA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX